Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Obstet Gynecol. 2010 Jan;115(1):35–40. doi: 10.1097/AOG.0b013e3181c4e864

Table 2.

Predictors of BMD loss ≥ 5% at the lumbar spine or femoral neck in DMPA users over 24 months of use

Characteristics Odds ratio (95% CI)
Race/ethnicity
   Black Reference
   White 0.34 (0.10–1.17)
   Hispanic 0.90 (0.26–3.10)
Previous DMPA injection (#) 0.90 (0.80–1.02)
Parity 0.49 (0.29–0.82)
Total calcium intake 0.81 (0.65–0.99)
Current smoker 3.88 (1.26–11.96)

Based on logistic regression analysis

R-squared value: 0.20

Area under the ROC curve: 0.79

P value for Hosmer-Lemeshow goodness of fit test=0.25

Dependent variable: BMD loss (≥ 5% vs. <5%)

Predictors: race/ethnicity (non-Hispanic black, non-Hispanic white, Hispanic), previous use of DMPA injection (# of injection), parity (continuous), total calcium intake (in 100 mg/day), current smoker (current smoker vs. not current smoker)